Drug & intervention

lidocaine

RxCUI 6387

Clinical trials21
Recruiting1
Related conditions20
Synonyms57

Understanding this RxNorm record

RxNorm identifiers distinguish ingredients, specific strengths, dose forms, and branded products. They help connect equivalent terminology across data sources; an RxNorm entry does not by itself establish that a product is currently marketed, approved for a particular use, or appropriate for an individual.

Clinical-trial associations reflect registry-reported intervention names and verified mappings where available. A medication listed in a trial may be investigational for that condition. Consult the original study record and official prescribing information for indications and safety details.

Terminology source: National Library of Medicine RxNorm. Trial source: ClinicalTrials.gov.

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Lidocaine

Lidocaine, also known as lignocaine and sold under the brand name Xylocaine among others, is a local anesthetic of the amino amide type. It is also used to treat ventricular tachycardia and ventricular fibrillation. When used for local anaesthesia or in nerve blocks, lidocaine typically begins working within several minutes and lasts for half an hour to three hours. Lidocaine mixtures may also be applied directly to the skin or mucous membranes to numb the area. It is often used mixed with a small amount of adrenaline (epinephrine) to prolong its local effects and to decrease bleeding. If injected intravenously, it may cause cerebral effects such as confusion, changes in vision, numbness, tingling, and vomiting. It can cause low blood pressure and an irregular heart rate. There are concerns that injecting it into a joint can cause problems with the cartilage. It appears to be generally safe for use in pregnancy. A lower dose may be required in those with liver problems. It is generally safe to use in those allergic to tetracaine or benzocaine. Lidocaine is an antiarrhythmic medication of the class Ib type. This means it works by blocking sodium channels thus decreasing the rate of contractions of the heart. When injected near nerves, the nerves cannot conduct signals to or from the brain. Lidocaine was discovered in 1946 and went on sale in 1948. It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication. In 2023, it was the 277th most commonly prescribed medication in the United States, with more than 800,000 prescripti...

Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

21 shown
Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity SurgeryNCT03756961 · 2019-05-01
RECRUITING
Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN TrialNCT06661902 · 2025-01-09
COMPLETED
Attenuation of the Hemodynamic Response to Double-lumen Endotracheal Intubation With Nebulized LidocaineNCT05850702 · 2023-06-15
UNKNOWN
Lidocaine IV Injection With Different Doses for Patients With Neuropathic Pain After MastectomyNCT07475520 · 2022-07-25
COMPLETED
Pharmacodynamic Study of BIIB095 and BIIB074 in Healthy Participants and Participants With Painful Diabetic PolyneuropathyNCT04106050 · 2020-09-30
WITHDRAWN
Serratus Anterior Muscle Plane Block vsThoracic Paravertebral Block For Unilateral MastectomiesNCT02822196 · 2018-12-01
WITHDRAWN
Intravenous Lidocaine in Bariatric Surgery.NCT03211455 · 2017-12-01
COMPLETED
Serum Opiorphin Level After Intraoperative Intravenous Lidocaine InfusionNCT03502395 · 2017-04-04
COMPLETED
The Impact of Intravenous Anaesthesia on Angiogenesis in Patients With Breast Cancer (TIVA/TCI-BC)NCT02839668 · 2016-08-01
COMPLETED
A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary HypertensionNCT02684786 · 2016-07-01
WITHDRAWN
Safety Profile of IntRAvenous Lidocaine Use in Coelioscopic Bariatric SurgeryNCT02525016 · 2015-09-01
COMPLETED
Lidocaine for Diabetic Peripheral NeuropathyNCT02363803 · 2015-02-01
COMPLETED
Effect of Perioperative Intravenous Lidocaine Infusion and Magnesium Infusion on the Functional Recovery After General Anesthesia in the Patients Undergoing Breast MastectomyNCT02185859 · 2014-07-01
COMPLETED
Clinical Assessment of the Treatment With Cardiac Sympathetic Blockade on Chronic Heart FailureNCT02391142 · 2014-06-01
UNKNOWN
Routine Irrigation With Ropivacaine vs. Lidocaine vs. Saline of Surgical Bed in Sleeve GastrectomyNCT02023684 · 2014-01-01
UNKNOWN
Intraoperative Lidocaine Infusion for Postoperative Pain Management in Obese PatientsNCT01944098 · 2013-08-01
COMPLETED
Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site PainNCT01433328 · 2012-01-01
TERMINATED
IRB-HSR# 13957: IV Lidocaine for Patients Undergoing Primary Breast Cancer Surgery:NCT01204242 · 2009-08-01
COMPLETED
Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate BiopsyNCT00441532 · 2005-08-01
COMPLETED
Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver DysfunctionNCT00540982 · 1997-02-20
COMPLETED
Anesthesia in Flexible Bronchoscopy for Lung Cancer DiagnosticNCT00440960
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.